The 'game changing' weekly injections have helped thousands of people who need to lose weight and improve their health. But ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

COPENHAGEN - The CEO of obesity drugmaker Novo Nordisk and heads of other Danish companies met on Thursday with Denmark's ...

The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

Geviti is not just a health optimization platform—it’s a revolutionary approach to wellness that invites you to take control ...

Popular obesity stocks fell on Tuesday after pharma giant Eli Lilly LLY lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth-quarter sales numbers. LLY’s ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...